Alpha 2.0
Login Register
» Articles » PMID: 16502004

Higher Incidence of Chemotherapy Induced Oral Mucositis in Females: a Supplement of Multivariate Analysis to a Randomized Multicentre Study

Overview
Journal Support Care Cancer
Specialties Critical Care
Oncology
Date 2006 Feb 28
PMID 16502004
Citations 27
Authors
Samuel Vokurka
Eva Bystricka
Vladimir Koza
Jana Scudlova
Vladislava Pavlicova
Dana Valentova
Maria Visokaiova
Lubica Misaniova
Affiliations
Soon will be listed here.
Abstract

Study on the normal saline vs povidone-iodine mouthwashes for oral mucositis (OM) prophylaxis in patients after high-dose chemotherapy comprising bischloroethyl nitrosourea etoposide ara-C melphalan (BEAM) or high-dose melphalan (HD-L-PAM) followed by autologous peripheral stem cell transplantation indicated that females have higher a incidence of OM compared to men, as reported by [Vokurka et al. 13:554-558, (2005)]. The multivariable analysis of larger cohort of 148 patients compliant with the original study protocol confirmed female gender to be an independent risk factor and predictor for OM. The HD-L-PAM (200 mg/m2) conditioning regimen revealed to be more toxic compared to BEAM as for incidence of OM grades 3-4 World Health Organization score. Body mass index, age, mouthwash solution used, and CD34+ cell number in the autologous graft were verified not to have an impact on OM incidence in this group of patients.

Citing Articles

Nuclear Receptors and Stress Response Pathways Associated with the Development of Oral Mucositis Induced by Antineoplastic Agents.

Kagaya M, Uesawa Y Pharmaceuticals (Basel). 2024; 17(8).

PMID: 39204191 PMC: 11358984. DOI: 10.3390/ph17081086.

Association of Insomnia and Obstructive Sleep Apnea with Worse Oral Mucositis and Quality of Life in Head and Neck Cancer Patients Undergoing Radiation Therapy.

Iovoli A, Smith K, Yu H, Kluczynski M, Jungquist C, Ray A Cancers (Basel). 2024; 16(7).

PMID: 38611012 PMC: 11011024. DOI: 10.3390/cancers16071335.

Oral Problems in Oncology Patients Undergoing Chemotherapy for Solid Tumors: A Prospective Observational Study.

Ottaviani G, Targato G, Rupel K, Gobbo M, Generali D, Guglielmi A Cancers (Basel). 2024; 16(1).

PMID: 38201603 PMC: 10778343. DOI: 10.3390/cancers16010176.

Risk factors for oral mucositis in patients with solid tumors under treatment with cetuximab: a retrospective cross-sectional study.

Martins J, Borges M, Malta C, Guerra J, Crispim A, Coelho B Med Oral Patol Oral Cir Bucal. 2023; 29(2):e248-e254.

PMID: 37992137 PMC: 10945870. DOI: 10.4317/medoral.26237.

Study of prevalence and risk factors of chemotherapy-induced mucositis in gastrointestinal cancer using machine learning models.

Huang L, Ye X, Wu F, Wang X, Qiu M Front Oncol. 2023; 13:1138992.

PMID: 37841443 PMC: 10569816. DOI: 10.3389/fonc.2023.1138992.

References
1.
Raber-Durlacher J, Weijl N, Abu Saris M, de Koning B, Zwinderman A, Osanto S . Oral mucositis in patients treated with chemotherapy for solid tumors: a retrospective analysis of 150 cases. Support Care Cancer. 2000; 8(5):366-71. DOI: 10.1007/s005200050004. View
2.
Robien K, Schubert M, Bruemmer B, Lloid M, Potter J, Ulrich C . Predictors of oral mucositis in patients receiving hematopoietic cell transplants for chronic myelogenous leukemia. J Clin Oncol. 2004; 22(7):1268-75. DOI: 10.1200/JCO.2004.05.147. View
3.
Sonis S, Elting L, Keefe D, Peterson D, Schubert M, Hauer-Jensen M . Perspectives on cancer therapy-induced mucosal injury: pathogenesis, measurement, epidemiology, and consequences for patients. Cancer. 2004; 100(9 Suppl):1995-2025. DOI: 10.1002/cncr.20162. View
4.
Vokurka S, Bystricka E, Koza V, Scudlova J, Pavlicova V, Valentova D . The comparative effects of povidone-iodine and normal saline mouthwashes on oral mucositis in patients after high-dose chemotherapy and APBSCT--results of a randomized multicentre study. Support Care Cancer. 2005; 13(7):554-8. DOI: 10.1007/s00520-005-0792-9. View